CoverageForm 410-K10-Q8-K13D13G13F

PHAS Phasebio Pharmaceuticals Inc - 8-K

Filed Jul 12, 2024. See issuer overview · financials · original on SEC.gov ↗
Accession
0001193125-24-178615
No items extracted yet - this filing's body hasn't been ingested (or the item parser couldn't find structured headings).